Record Layout   Sample Data  Purchase

File Description / Details:

Reverse Crosswalks ICD10 Diagnosis Codes to HCPCS/CPT Medical Procedures 

HCPCS_CODE

Longdesc

ICD10_CODE

LDesc

Indicator

NMD

LCD

ARTICLE

J9201

Injection, gemcitabine hydrochloride, 200 mg

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.0

Liver cell carcinoma

1

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.1

Intrahepatic bile duct carcinoma

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.2

Hepatoblastoma

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.3

Angiosarcoma of liver

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.4

Other sarcomas of liver

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.7

Other specified carcinomas of liver

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.8

Malignant neoplasm of liver, primary, unspecified as to type

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C22.9

Malignant neoplasm of liver, not specified as primary or secondary

1

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C23

Malignant neoplasm of gallbladder

1

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C24.0

Malignant neoplasm of extrahepatic bile duct

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C24.1

Malignant neoplasm of ampulla of Vater

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C24.8

Malignant neoplasm of overlapping sites of biliary tract

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C24.9

Malignant neoplasm of biliary tract, unspecified

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.0

Malignant neoplasm of head of pancreas

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.1

Malignant neoplasm of body of pancreas

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.2

Malignant neoplasm of tail of pancreas

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.3

Malignant neoplasm of pancreatic duct

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.4

Malignant neoplasm of endocrine pancreas

1

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.7

Malignant neoplasm of other parts of pancreas

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.8

Malignant neoplasm of overlapping sites of pancreas

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C25.9

Malignant neoplasm of pancreas, unspecified

1

X

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C26.9

Malignant neoplasm of ill-defined sites within the digestive system

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C30.0

Malignant neoplasm of nasal cavity

1

X

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C30.1

Malignant neoplasm of middle ear

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C31.0

Malignant neoplasm of maxillary sinus

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C31.1

Malignant neoplasm of ethmoidal sinus

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C31.2

Malignant neoplasm of frontal sinus

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C31.3

Malignant neoplasm of sphenoid sinus

1

X

J9201

Injection, gemcitabine hydrochloride, 200 mg

C31.8

Malignant neoplasm of overlapping sites of accessory sinuses

1

X

ICD10_CODE

LDesc

Indicator

HCPCS_CODE

Longdesc

NMD

LCD

ARTICLE

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

74177

Computed tomography, abdomen and pelvis; with contrast material(s)

X

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

74178

Computed tomography, abdomen and pelvis; without contrast material in one or both body regions, followed by contrast material(s) and further sections in one or both body regions

X

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

74183

Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

74261

Computed tomographic (CT) colonography, diagnostic, including image postprocessing; without contrast material

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

74262

Computed tomographic (CT) colonography, diagnostic, including image postprocessing; with contrast material(s) including non-contrast images, if performed

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

74263

Computed tomographic (CT) colonography, screening, including image postprocessing

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

74270

Radiologic examination, colon; contrast (eg, barium) enema, with or without KUB

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

76376

3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; not requiring image postprocessing on an independent workstation

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

76700

Ultrasound, abdominal, real time with image documentation; complete

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

76857

Ultrasound, pelvic (nonobstetric), real time with image documentation; limited or follow-up (eg, for follicles)

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

76872

Ultrasound, transrectal;

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

76873

Ultrasound, transrectal; prostate volume study for brachytherapy treatment planning (separate procedure)

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77001

Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or catheter with related venography radiologic supervision and interpretation, and radiographic documentation of final catheter position) (List separately in addition to code for primary procedure)

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77014

Computed tomography guidance for placement of radiation therapy fields

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77263

Therapeutic radiology treatment planning; complex

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77280

Therapeutic radiology simulation-aided field setting; simple

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77290

Therapeutic radiology simulation-aided field setting; complex

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77295

3-dimensional radiotherapy plan, including dose-volume histograms

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77300

Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, only when prescribed by the treating physician

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77301

Intensity modulated radiotherapy plan, including dose-volume histograms for target and critical structure partial tolerance specifications

X

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77307

Teletherapy isodose plan; complex (multiple treatment areas, tangential ports, the use of wedges, blocking, rotational beam, or special beam considerations), includes basic dosimetry calculation(s)

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77321

Special teletherapy port plan, particles, hemibody, total body

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77331

Special dosimetry (eg, TLD, microdosimetry) (specify), only when prescribed by the treating physician

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77334

Treatment devices, design and construction; complex (irregular blocks, special shields, compensators, wedges, molds or casts)

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77336

Continuing medical physics consultation, including assessment of treatment parameters, quality assurance of dose delivery, and review of patient treatment documentation in support of the radiation oncologist, reported per week of therapy

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77338

Multi-leaf collimator (MLC) device(s) for intensity modulated radiation therapy (IMRT), design and construction per IMRT plan

X

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77370

Special medical radiation physics consultation

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77385

Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; simple

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77386

Intensity modulated radiation treatment delivery (IMRT), includes guidance and tracking, when performed; complex

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77417

Therapeutic radiology port image(s)

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77427

Radiation treatment management, 5 treatments

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77470

Special treatment procedure (eg, total body irradiation, hemibody radiation, per oral or endocavitary irradiation)

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77520

Proton treatment delivery; simple, without compensation

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77522

Proton treatment delivery; simple, with compensation

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77523

Proton treatment delivery; intermediate

X

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

77525

Proton treatment delivery; complex

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

78459

Myocardial imaging, positron emission tomography (PET), metabolic evaluation

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

78472

Cardiac blood pool imaging, gated equilibrium; planar, single study at rest or stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without additional quantitative processing

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

78473

Cardiac blood pool imaging, gated equilibrium; multiple studies, wall motion study plus ejection fraction, at rest and stress (exercise and/or pharmacologic), with or without additional quantification

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

78481

Cardiac blood pool imaging (planar), first pass technique; single study, at rest or with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification

X

C21.8

Malignant neoplasm of overlapping sites of rectum, anus and anal canal

1

78483

Cardiac blood pool imaging (planar), first pass technique; multiple studies, at rest and with stress (exercise and/or pharmacologic), wall motion study plus ejection fraction, with or without quantification

X

04/02/18